Microglia-Derived Adiposomes Are Potential Targets for the Treatment of Ischemic Stroke

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2019 Mar 11

PMID 30852719

Citations 7

Authors

Chi-Hsin Lin

Li-Ya Liao

Tsung-Ying Yang

Yi-Jyun Chang

Chia-Wen Tung

Shih-Lan Hsu

Chi-Mei Hsueh

Affiliations

Soon will be listed here.

Abstract

It is known that cerebral ischemia can cause brain inflammation and adiposome can serve as a depot of inflammatory mediators. In the study, the pro-inflammatory and pro-death role of adiposome in ischemic microglia and ischemic brain was newly investigated. The contribution of PPARγ to adiposome formation was also evaluated for the first time in ischemic microglia. Focal cerebral ischemia/reperfusion (I/R) animal model and the in vitro glucose-oxygen-serum deprivation (GOSD) cell model were both applied in the study. GOSD- or I/R-induced adiposome formation, inflammatory activity, cell death of microglia, and brain infarction were, respectively, determined, in the absence or presence of NS-398 (adiposome inhibitor) or GW9662 (PPARγ antagonist). GOSD-increased adiposome formation played a critical role in stimulating the inflammatory activity (production of TNF-α and IL-1β) and cell death of microglia. Similar results were also found in ischemic brain tissues. GOSD-induced PPARγ partially contributed to the increase of adiposomes and adiposome-mediated inflammatory responses of microglia. Blockade of adiposome formation with NS-398 or GW9662 significantly reduced not only the inflammatory activity and death rate of GOSD-treated microglia but also the brain infarct volume and motor function deficit of ischemic rats. The pathological role of microglia-derived adiposome in cerebral ischemia has been confirmed and attributed to its pro-inflammatory and/or pro-death effect upon ischemic brain cells and tissues. Adiposome and its upstream regulator PPARγ were therefore as potential targets for the treatment of ischemic stroke. Therapeutic values of NS-398 and GW9662 have been suggested.

Citing Articles

Lipid droplets in central nervous system and functional profiles of brain cells containing lipid droplets in various diseases.

Zhang L, Zhou Y, Yang Z, Jiang L, Yan X, Zhu W J Neuroinflammation. 2025; 22(1):7.

PMID: 39806503 PMC: 11730833. DOI: 10.1186/s12974-025-03334-5.

Dynamic Brain Lipid Profiles Modulate Microglial Lipid Droplet Accumulation and Inflammation Under Ischemic Conditions in Mice.

Wei W, Lattau S, Xin W, Pan Y, Tatenhorst L, Zhang L Adv Sci (Weinh). 2024; 11(41):e2306863.

PMID: 39252446 PMC: 11538718. DOI: 10.1002/advs.202306863.

Knockdown of NEAT1 prevents post-stroke lipid droplet agglomeration in microglia by regulating autophagy.

Pan Y, Xin W, Wei W, Tatenhorst L, Graf I, Popa-Wagner A Cell Mol Life Sci. 2024; 81(1):30.

PMID: 38212456 PMC: 10784396. DOI: 10.1007/s00018-023-05045-7.

The regulatory role of lipophagy in central nervous system diseases.

Lan Z, Ge Z, Lv S, Zhao B, Li C Cell Death Discov. 2023; 9(1):229.

PMID: 37414782 PMC: 10326259. DOI: 10.1038/s41420-023-01504-z.

Effects of Microglial Activation and Polarization on Brain Injury After Stroke.

Dong R, Huang R, Wang J, Liu H, Xu Z Front Neurol. 2021; 12:620948.

PMID: 34276530 PMC: 8280287. DOI: 10.3389/fneur.2021.620948.

References

Jin R, Yang G, Li G . Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5):779-89. PMC: 2858674. DOI: 10.1189/jlb.1109766. View

Zoccal K, Paula-Silva F, Bitencourt C, Sorgi C, de Castro Figueiredo Bordon K, Arantes E . PPAR-γ activation by Tityus serrulatus venom regulates lipid body formation and lipid mediator production. Toxicon. 2014; 93:90-7. DOI: 10.1016/j.toxicon.2014.11.226. View

Wu M, Hou M, Lin Y, Kuo C . 2,4,5-TMBA, a natural inhibitor of cyclooxygenase-2, suppresses adipogenesis and promotes lipolysis in 3T3-L1 adipocytes. J Agric Food Chem. 2012; 60(29):7262-9. DOI: 10.1021/jf302285k. View

Lin C, Wang C, Hsu S, Liao L, Lin T, Hsueh C . Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain. PLoS One. 2016; 11(1):e0146692. PMC: 4706329. DOI: 10.1371/journal.pone.0146692. View

Lee J, Dutta R, Kim S, Lim J, Kim S, Choe S . Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process. Biochem Biophys Res Commun. 2013; 442(1-2):22-7. DOI: 10.1016/j.bbrc.2013.10.140. View

Defaux A, Zurich M, Braissant O, Honegger P, Monnet-Tschudi F . Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J Neuroinflammation. 2009; 6:15. PMC: 2687435. DOI: 10.1186/1742-2094-6-15. View

Muller G, Jung C, Wied S, Biemer-Daub G, Frick W . Transfer of the glycosylphosphatidylinositol-anchored 5'-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis. Br J Pharmacol. 2010; 160(4):878-91. PMC: 2935995. DOI: 10.1111/j.1476-5381.2010.00724.x. View

Hundsberger H, Verin A, Wiesner C, Pfluger M, Dulebo A, Schutt W . TNF: a moonlighting protein at the interface between cancer and infection. Front Biosci. 2008; 13:5374-86. DOI: 10.2741/3087. View

Fagundes Assumpcao J, Magalhaes K, Correa J . The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation. Cancer Cell Int. 2017; 17:82. PMC: 5603033. DOI: 10.1186/s12935-017-0451-5. View

10.

Nagayama M, Niwa K, Nagayama T, Ross M, Iadecola C . The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab. 1999; 19(11):1213-9. DOI: 10.1097/00004647-199911000-00005. View

11.

Kuroda M, Sakaue H . Adipocyte Death and Chronic Inflammation in Obesity. J Med Invest. 2017; 64(3.4):193-196. DOI: 10.2152/jmi.64.193. View

12.

Bozza P, Payne J, Morham S, Langenbach R, SMITHIES O, Weller P . Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A. 1996; 93(20):11091-6. PMC: 38289. DOI: 10.1073/pnas.93.20.11091. View

13.

Bozza P, Pacheco P, Yu W, Weller P . NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot Essent Fatty Acids. 2002; 67(4):237-44. DOI: 10.1054/plef.2002.0425. View

14.

Ramanan S, Kooshki M, Zhao W, Hsu F, Riddle D, Robbins M . The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. Int J Radiat Oncol Biol Phys. 2009; 75(3):870-7. PMC: 2789462. DOI: 10.1016/j.ijrobp.2009.06.059. View

15.

Candelario-Jalil E, Ajamieh H, Sam S, Martinez G, Leon Fernandez O . Nimesulide limits kainate-induced oxidative damage in the rat hippocampus. Eur J Pharmacol. 2000; 390(3):295-8. DOI: 10.1016/s0014-2999(99)00908-5. View

16.

Beil W, Weller P, Peppercorn M, Galli S, Dvorak A . Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol. 1995; 58(3):284-98. DOI: 10.1002/jlb.58.3.284. View

17.

Fan B, Ikuyama S, Gu J, Wei P, Oyama J, Inoguchi T . Oleic acid-induced ADRP expression requires both AP-1 and PPAR response elements, and is reduced by Pycnogenol through mRNA degradation in NMuLi liver cells. Am J Physiol Endocrinol Metab. 2009; 297(1):E112-23. DOI: 10.1152/ajpendo.00119.2009. View

18.

England H, Summersgill H, Edye M, Rothwell N, Brough D . Release of interleukin-1α or interleukin-1β depends on mechanism of cell death. J Biol Chem. 2014; 289(23):15942-50. PMC: 4047367. DOI: 10.1074/jbc.M114.557561. View

19.

Donnan G, Fisher M, Macleod M, Davis S . Stroke. Lancet. 2008; 371(9624):1612-23. DOI: 10.1016/S0140-6736(08)60694-7. View

20.

Lin J, Liu Q, Zhang H, Huang X, Zhang R, Chen S . C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways. Oncotarget. 2017; 8(47):82541-82557. PMC: 5669909. DOI: 10.18632/oncotarget.19657. View